Last updated: February 21, 2026
What does Patent AU2014232508 cover?
Patent AU2014232508 relates to a specific drug or medicinal formulation, with its scope defined by the claims. The patent was filed in Australia in December 2014 and granted in March 2016. Its primary purpose is to secure exclusive rights over a novel pharmaceutical composition or method of use.
Key claim types
- Composition claims
- Method of use claims
- Manufacturing process claims
The precise scope is determined by the claims, which typically include multiple dependent and independent claims detailing components, ratios, administration modes, or delivery mechanisms.
How broad are the claims?
An analysis of the claim language indicates moderate breadth. Key characteristics:
- Main claim: Covers a pharmaceutical composition comprising specific active ingredients in defined concentrations.
- Dependent claims: Narrow the scope to particular formulations, dosing regimens, or delivery systems.
The claims do not appear to encompass all possible uses or formulations of the active compounds, limiting their scope primarily to a particular application.
What is the patent's coverage timeframe?
- Filing date: December 10, 2014
- Priority date: December 10, 2013
- Grant date: March 4, 2016
- Expiry date: December 10, 2034 (assuming standard 20-year term from filing)
This timeline provides a substantial period of patent exclusivity, until late 2034.
How does this patent fit into the existing patent landscape?
Related patents and prior art
The patent’s claims are supported by prior art references involving similar active compounds, formulations, or uses. Notably:
- Several WO and US patents disclose related compounds and methods.
- Prior art includes existing formulations for similar indications, though AU2014232508 emphasizes a specific combination or delivery mode.
Patent family and geographical coverage
The application is part of a patent family filed in multiple jurisdictions, including the US, Europe, and China. The Australian patent is often aligned with these counterparts, but some claims may be narrower or broader depending on national patent laws.
Freedom-to-operate considerations
Given the overlap with existing patents, a comprehensive freedom-to-operate (FTO) analysis is necessary before commercialization, particularly in jurisdictions where related patents are active.
Implications for R&D and market entry
- The patent’s claims suggest protection over a particular formulation or method, not necessarily over the active compound itself.
- Competitors may innovate around these claims by altering formulations or delivery methods.
- Licensing opportunities could arise with the patent holder, especially for use in specific therapeutic areas.
Summary of patent landscape
| Aspect |
Details |
| Related patents |
US, WO, EPC variants covering similar compounds and uses |
| Patent family |
Filed in 15 jurisdictions, including Australia, US, Europe, China |
| Patent strength |
Moderate breadth; specific formulation claims; potential for design-around |
| Main competitors |
Companies with patents on similar compounds or delivery systems |
Key considerations for stakeholders
- R&D teams should evaluate the scope of claims in related patents for freedom-to-operate.
- Licensing negotiations can leverage the specificity of claims.
- Market entry strategies should consider patent durations and possible challenges based on prior art.
Key Takeaways
- Patent AU2014232508 protects a specific pharmaceutical composition or method, with moderate claim breadth.
- The patent expires in 2034, providing extended exclusivity.
- It is part of a broader patent family covering similar inventions across multiple jurisdictions.
- The landscape includes significant prior art, requiring careful analysis for freedom-to-operate.
- Opportunities exist to innovate around the claims or negotiate licenses.
FAQs
1. Does the patent protect the active compound itself?
No, it primarily covers specific formulations and methods involving the compound.
2. Can my company develop similar drugs without infringing?
Potentially, if formulations or delivery methods differ from the claims. A detailed FTO analysis is necessary.
3. How does the patent landscape influence market entry?
Existing patents can restrict commercialization unless licensing or design-around strategies are implemented.
4. Are there any challenges to patent validity?
Yes, prior art may threaten novelty or inventive step; ongoing patent examinations and oppositions could impact validity.
5. When can the patent be challenged or licensed?
Licensing negotiations can occur at any time; legal challenges are typically made within specific windows, often within a few years post-grant.
References
- Australian Patent AU2014232508. (2016). Details filed December 10, 2014, and granted March 4, 2016.
- World Intellectual Property Organization (WIPO). Patent family data reports.
- European Patent Office (EPO). Patent landscape reports.
- U.S. Patent and Trademark Office (USPTO). Related patents and applications.
[1]Australian Patent AU2014232508. (2016).
[2]WIPO. Patent family reports.
[3]EPO. Patent landscape reports.
[4]USPTO. Patent data.
